Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock

Pfizer and Sangamo’s haemophilia A gene therapy shows promise at Phase 1/2

July 8, 2019
Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma

Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …

News
8655563196_1c0f83c447_z

New urine test can diagnose and offer prognosis for prostate cancer

July 8, 2019
Sales and Marketing Cancer, oncology, pharma, prostate cancer, urine test

A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …

News
29496564944_a9faceb1c2_z

Trump says executive order will ensure US will pay lowest prices in the world for drugs

July 8, 2019
Sales and Marketing Trump, US, executive order, pharma, politics, pricing

President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …

News
gsk_china_2_2_0_1

GSK opens new manufacturing plants in Singapore

July 5, 2019
Manufacturing and Production Asia, HIV, Singapore, anaemia, facilities, manufacturing, pharma

British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore. The UK firm has also expanded facilities at its …

News
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Mike Thompson, pharma

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma

The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …

News
16792957331_d9572dbdf4_z

FDA sharpen focus on pharmaceutical companies under Trump

July 5, 2019
Medical Communications FDA, Obama, Trump, USA, pharma, regulation

The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …

News

NICE recommends Pfizer’s Vizimpro, rejects AstraZeneca’s Tagrisso, in non-small cell lung cancer

July 5, 2019
Medical Communications, Sales and Marketing Cancer, NHS, NICE, Pfizer, UK, Vizimpro, lung cancer, pharma

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …

News

Scientists use cold virus to treat bladder cancer

July 5, 2019
Medical Communications, Research and Development CVA21, Cancer, bladder cancer, oncology, oncolytic, pharma, virus

A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer …

News
dw-anzcxqaqavhl

FDA approves multiple myeloma therapy Xpovio despite safety concerns

July 4, 2019
Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma

The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …

News

Cancer cost US more than $94 billion in lost earnings in 2015

July 4, 2019
Research and Development Cancer, economics, health, lost earnings, oncology, pharma

Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer …

News
shutterstock_138095450_13

Prices hiked on 3,400 drugs in first half of 2019

July 4, 2019
Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing

There have been price hikes on more than 3,400 drugs in the United States in the first six months of …

News
alexion_sign

European approval for Alexion’s Ultomiris in rare blood disease

July 4, 2019
Sales and Marketing Alexion, Europe, Ultomiris, paroxysmal nocturnal haemoglobinuria

Alexion has received marketing authorisation from the European Commission for its long-acting C5 complement inhibitor Ultomiris (ravulizumab) in the treatment …

News
medicinal_cannabis_uk_review

UK Government call for more research into medicinal cannabis

July 4, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …

News
landing-hero-images1

ViiV’s Dovato approved in Europe as treatment option for HIV-1

July 3, 2019
Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma

ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …

News
1920px-hiv-budding-color

Researchers use gene-editing tool CRISPR to cure mice of HIV

July 3, 2019
Research and Development AIDS, HIV, Nature Communications, crispr, mice, pharma

American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to …

News

Roche’s Xofluza proves non-inferior to Tamiflu in children with flu

July 3, 2019
Research and Development Roche, Tamiflu, flu, pharma

Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …

News

US Government awarded new patent on preventative HIV drugs PrEP

July 3, 2019
Research and Development, Sales and Marketing Gilead, HHS, government, pharma

The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV. The …

News

Elizabeth Warren calls on former FDA commissioner Scott Gottlieb to resign from board of Pfizer

July 2, 2019
Research and Development FDA, Pfizer, Scott Gottlieb, health, pharma, public health

Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer.   In a letter to Gottlieb, Senator Warren …

News

Biogen unveils promising new data for Spinraza in pre-symptomatic infants with spinal muscular atrophy

July 2, 2019
Manufacturing and Production, Research and Development Biogen, Spinraza, pharma, spinal muscular atrophy

Biogen has introduced new data on the efficacy of Spinraza in the treatment of pre-symptomatic infants in spinal muscular atrophy …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026